Cinacalcet decreased osteoclast bone resorption as determined by TRAP in the in-vitro study, however, it preserved osteoclast number for osteoclast-osteoblast interaction in in-vivo CKD mice. This evidence concerns the gene ACP5 and chronic kidney disease.